|
BV-2 cells
|
984.93 μM
|
CCK-8 assay
|
PMC11369507
|
|
SUM44PE, MM134, MM330, WCRC25, MM453, HCC2185, MCF7, T47D, MM415, BT474
|
ILC cell lines: 27 µM (median); NST cell lines: 78.5 µM (med
|
CellTiter-Glo, nonlinear regression, sum-of-squares Global f-test
|
PMC11526681
|
|
human colon muscle strips
|
0.468 µM
|
nonlinear regression analysis, Y= 100/(1 + 10 ^((LogIC50−X)*Hill Slope)), was performed to asses s the effect of forskolin on myogenic contractions.
|
Download PDF
|
|
Toledo
|
40 µM
|
MTT assay
|
PMC6388987
|
|
NK-92
|
40 µM
|
MTT assay
|
PMC6388987
|
|
GUMC-403
|
1.670 uM
|
reagent luminescence signal assay
|
Download PDF
|
|
GUMC-403
|
5.157 uM
|
Luminescent Cell Viability Assay
|
Download PDF
|
|
GUMC-403
|
1.920 uM
|
3D Cell Viability Assay from dose-response curves
|
Download PDF
|
|
CAL-51
|
48 ± 3.3 µM
|
Luminescent Cell Viability Assay
|
Download PDF
|
|
MDA-MB-453
|
38 ± 5.3 µM
|
Luminescent Cell Viability Assay
|
Download PDF
|
|
KM12
|
4 ± 0.3 µM
|
Luminescent Cell Viability Assay
|
Download PDF
|
|
BxPC-3
|
45 ± 3.1 µM
|
Luminescent Cell Viability Assay
|
Download PDF
|
|
HeLa
|
58.15 mg/mL
|
MTT-test
|
PMC6362157
|
|
HepG2
|
72.75 mg/mL
|
MTT-test
|
PMC6362157
|
|
HT-29
|
40.72 mg/mL
|
MTT-test
|
PMC6362157
|
|
Rat platelet-rich-plasma
|
1.110 ± 0.1564 µg/mL
|
ADP-induced platelet aggregation assay, calculated based on nonlinear fit of log values using GraphPad Prism
|
Download PDF
|
|
3T3 murine embryonic fibroblasts
|
4.7 μM
|
Spheroid contraction rate measurement over 150 min, fit to a Boltzmann sigmoidal function.
|
Download PDF
|